Diversified Trust’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Sell
5,434
-13,123
-71% -$948K 0.01% 800
2026
Q1
$1.26M Buy
18,557
+1,163
+7% +$82.4K 0.02% 388
2025
Q4
$1.32M Buy
17,394
+817
+5% +$59.4K 0.02% 354
2025
Q3
$1.02M Buy
16,577
+744
+5% +$38.8K 0.02% 419
2025
Q2
$773K Sell
15,833
-1,314
-8% -$62.4K 0.02% 450
2025
Q1
$874K Buy
17,147
+329
+2% +$16.4K 0.02% 408
2024
Q4
$759K Buy
16,818
+1,578
+10% +$67.5K 0.02% 458
2024
Q3
$565K Sell
15,240
-77
-0.5% -$2.58K 0.01% 558
2024
Q2
$468K Buy
15,317
+818
+6% +$26.5K 0.01% 556
2024
Q1
$422K Buy
14,499
+295
+2% +$8.26K 0.01% 554
2023
Q4
$391K Buy
14,204
+896
+7% +$20.5K 0.01% 573
2023
Q3
$298K Buy
13,308
+318
+2% +$11.8K 0.01% 619
2023
Q2
$528K Buy
12,990
+695
+6% +$34K 0.02% 446
2023
Q1
$596K Buy
12,295
+3,806
+45% +$174K 0.02% 406
2022
Q4
$324K Sell
8,489
-9
-0.1% -$374 0.01% 555
2022
Q3
$427K Buy
8,498
+422
+5% +$20.7K 0.02% 442
2022
Q2
$324K Sell
8,076
-49
-0.6% -$1.72K 0.01% 538
2022
Q1
$303K Sell
8,125
-252
-3% -$9.71K 0.01% 614
2021
Q4
$334K Buy
+8,377
New +$321K 0.01% 601
2020
Q4
Sell
-6,064
Closed -$283K 774
2020
Q3
$283K Sell
6,064
-243
-4% -$12K 0.01% 466
2020
Q2
$320K Buy
+6,307
New +$310K 0.02% 372
2015
Q1
Sell
-4,015
Closed -$208K 509
2014
Q4
$208K Buy
+4,015
New +$177K 0.02% 472

Other funds holding PTCT

Diversified Trust's PTCT Position: Q2 2026 in Review

Diversified Trust reduced its PTC Therapeutics (PTCT) stake by 71% in Q2 2026, selling an estimated $948K and leaving 5,434 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #800.

Diversified Trust first reported a position in PTCT in Q4 2014 and has held it in 22 quarters since. The position peaked at $1.32M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Diversified Trust held 5,434 shares of PTC Therapeutics worth $443K as of Q2 2026.
  • Diversified Trust sold 13,123 PTC Therapeutics shares in Q2 2026, an estimated $948K.
  • PTC Therapeutics made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #800 holding.
  • Diversified Trust first reported a position in PTC Therapeutics in Q4 2014 and has held it in 22 quarters since.
  • Diversified Trust's PTC Therapeutics position peaked at $1.32M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.